Steroid Linked to Meningitis Outbreak Not Used at Mission Health
ASHEVILLE, N.C. (Oct. 4, 2012) - Mission Health officials have confirmed that Mission Hospital and its other member hospitals have not purchased or used the injectable steroid that has been linked to a rare meningitis outbreak.
On Wednesday, the U.S. Food and Drug Administration confirmed that a New England compounding center in Framingham, Mass., voluntarily recalled three lots of 80-milligram injection doses of methylprednisolone acetate (PF) Sept. 26. The lots included #05212012@68 with a beyond use date of Nov. 17, 2012; #06292012@26 with a beyond use date of Dec. 26, 2012; and #08102012@51 with a beyond use date of Feb. 6, 2013.
Mission Health will continue to keep the community informed on any new developments associated with the outbreak.